Lipocine Inc Sustainability Reports
Lipocine Inc. is a clinical-stage biopharmaceutical company focused on developing innovative oral therapeutics for neurodegenerative, metabolic, and central nervous system disorders. The company leverages its proprietary drug delivery technology platform to enhance the delivery and efficacy of pharmaceutical options.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300RXPEQXOJXVBI10
FIGI: BBG0029L1Y76
5 reports from 2013 to 2024
